CMND
Clearmind Medicine·NASDAQ
--
--(--)
--
--(--)
0.81 / 10
Underperform
The fundamental analysis of Clearmind Medicine (CMND) reveals a very low score of 0.8/10, primarily due to negative metrics such as Net profit margin (%) at -1256.29 and Net profit / Total operating revenue (%) at -265.09, both in group 1 with poor historical returns. Positive aspects include Asset-MV (group 3, score 2) and Net profit attributable to parent company shareholders / Net profit (%) at 100% (group 1, score 2), but these are insufficient to offset the overall weakness. The company's revenue growth is strong at 45.97% YoY, yet profitability remains a critical concern, leading to an overall negative fundamental stance.
Analysis Checks(2/10)
Revenue-MV
Value0.16
Score0/3
Weight9.24%
1M Return-2.92%
Value0.16
Score0/3
Weight9.24%
1M Return-2.92%
Total operating revenue (YoY growth rate %)
Value45.97
Score0/3
Weight13.86%
1M Return-6.59%
Value45.97
Score0/3
Weight13.86%
1M Return-6.59%
Net income-Revenue
Value0.15
Score1/3
Weight1.91%
1M Return-0.69%
Value0.15
Score1/3
Weight1.91%
1M Return-0.69%
Current assets turnover ratio
Value2.56
Score1/3
Weight4.65%
1M Return-1.72%
Value2.56
Score1/3
Weight4.65%
1M Return-1.72%
Asset-MV
Value-0.50
Score2/3
Weight1.29%
1M Return-0.42%
Value-0.50
Score2/3
Weight1.29%
1M Return-0.42%
Net profit attributable to parent company shareholders / Net profit (%)
Value100.00
Score2/3
Weight4.27%
1M Return-1.63%
Value100.00
Score2/3
Weight4.27%
1M Return-1.63%
Net cash flow from operating activities / Operating revenue (%)
Value-1393.65
Score0/3
Weight16.00%
1M Return-7.70%
Value-1393.65
Score0/3
Weight16.00%
1M Return-7.70%
Net profit margin (%)
Value-1256.29
Score0/3
Weight16.67%
1M Return-8.03%
Value-1256.29
Score0/3
Weight16.67%
1M Return-8.03%
EBIT / Total operating revenue (%)
Value-512.37
Score0/3
Weight15.77%
1M Return-7.44%
Value-512.37
Score0/3
Weight15.77%
1M Return-7.44%
Net profit / Total operating revenue (%)
Value-265.09
Score0/3
Weight16.35%
1M Return-7.85%
Value-265.09
Score0/3
Weight16.35%
1M Return-7.85%
Revenue-MV
Value0.16
Score0/3
Weight9.24%
1M Return-2.92%
Value0.16
Score0/3
Weight9.24%
1M Return-2.92%
Net profit attributable to parent company shareholders / Net profit (%)
Value100.00
Score2/3
Weight4.27%
1M Return-1.63%
Value100.00
Score2/3
Weight4.27%
1M Return-1.63%
Total operating revenue (YoY growth rate %)
Value45.97
Score0/3
Weight13.86%
1M Return-6.59%
Value45.97
Score0/3
Weight13.86%
1M Return-6.59%
Net cash flow from operating activities / Operating revenue (%)
Value-1393.65
Score0/3
Weight16.00%
1M Return-7.70%
Value-1393.65
Score0/3
Weight16.00%
1M Return-7.70%
Net income-Revenue
Value0.15
Score1/3
Weight1.91%
1M Return-0.69%
Value0.15
Score1/3
Weight1.91%
1M Return-0.69%
Net profit margin (%)
Value-1256.29
Score0/3
Weight16.67%
1M Return-8.03%
Value-1256.29
Score0/3
Weight16.67%
1M Return-8.03%
Current assets turnover ratio
Value2.56
Score1/3
Weight4.65%
1M Return-1.72%
Value2.56
Score1/3
Weight4.65%
1M Return-1.72%
EBIT / Total operating revenue (%)
Value-512.37
Score0/3
Weight15.77%
1M Return-7.44%
Value-512.37
Score0/3
Weight15.77%
1M Return-7.44%
Asset-MV
Value-0.50
Score2/3
Weight1.29%
1M Return-0.42%
Value-0.50
Score2/3
Weight1.29%
1M Return-0.42%
Net profit / Total operating revenue (%)
Value-265.09
Score0/3
Weight16.35%
1M Return-7.85%
Value-265.09
Score0/3
Weight16.35%
1M Return-7.85%
Is CMND undervalued or overvalued?
- CMND scores 0.81/10 on fundamentals and holds a Premium valuation at present. Backed by its -179.39% ROE, 0.00% net margin, -0.52 P/E ratio, 1.70 P/B ratio, and 55.24% earnings growth, these metrics solidify its Underperform investment rating.
